Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
¿Cuáles son los estados financieros clave de Wellgistics Health Inc?
Según el último estado financiero (Form-10K), Wellgistics Health Inc tiene un total de activos de $0, una ganancia neta 손실 de $0
¿Cuáles son los ratios financieros clave para WGRX?
El ratio corriente de Wellgistics Health Inc es 0, el margen neto es 0, las ventas por acción son $0.
¿Cómo se desglosan los ingresos de Wellgistics Health Inc por segmento o geografía?
Wellgistics Health Inc 주요 수익원은 Aerospace and Defense이며, 최신 수익 발표에서 수익은 1,768,600,000입니다. 지역별로는 United States이 Wellgistics Health Inc의 주요 시장이며, 수익은 1,699,900,000입니다.
¿Es rentable Wellgistics Health Inc?
no, según los últimos estados financieros, Wellgistics Health Inc tiene una ganancia neta 손실 de $0
¿Tiene Wellgistics Health Inc alguna deuda?
no, Wellgistics Health Inc tiene una deuda de 0
¿Cuántas acciones en circulación tiene Wellgistics Health Inc?
Wellgistics Health Inc tiene un total de acciones en circulación de 0